How has private equity changed veterinary medicine, and what does it mean for owners and staff?

Private equity describes investment firms that raise pooled capital from investors, buy companies outright or take control of them, work to increase the value, and sell them later to return a profit to those investors.

In veterinary medicine, that buying happens through platforms: practice groups that own and operate clinics across general practice, emergency and specialty care.

Thrive Pet Healthcare described itself in March 2025 as the owner-operator of over 360 veterinary hospitals, with TSG Consumer Partners as its equity sponsor.

As of the FTC's June 2022 order, JAB Consumer Partners was the parent company of two firms operating chains of clinics, National Veterinary Associates and Compassion-First Pet Hospitals.

Regulators have paid attention.

The FTC's Bureau of Competition director said in 2022 that private equity firms "increasingly engage in roll up strategies that allow them to accrue market power off the Commission's radar" — buying practice by practice, below the FTC's merger-reporting radar, rather than in one reviewable merger.

The FTC's veterinary record goes back further.

In 2017 it required Mars to divest 12 specialty and emergency clinics as a condition of its $9.1 billion acquisition of VCA Inc. The agency's private-equity language comes from its 2022 JAB actions, quoted above.

Here is what each order required:

Read together, the orders show what regulators watch in this sector: local markets for specialty and emergency care, and the specialists who staff them.

The FTC's Ethos complaint described the deal as part of "a growing trend towards consolidation in the emergency and specialty veterinary services markets across the United States in recent years by large chains."

A roll-up starts with a platform: the first practice group a firm buys becomes the base the rest are added to.

After that the model is repetition — acquire more practices, integrate them onto shared systems and management, and keep building until the group is worth more as a whole than the sum of what the firm paid for the pieces.

The engine underneath is called multiple arbitrage.

Practices are valued as a multiple of their earnings.

A larger, diversified platform with centralized management can command a higher multiple than a single-site practice can, and the spread between the prices paid for individual practices and the valuation of the platform that holds them is the return mechanism the strategy is built on.

We won't put example numbers on that arithmetic, deliberately: no published source we rely on works through one, and real deal terms vary too much for a tidy illustration.

If a broker or adviser sketches buy-at-this, sell-at-that math on a whiteboard, treat it as a sales pitch until it survives diligence.

Some deals also ask the seller to keep a stake in the platform instead of cashing out completely — rollover equity.

We have not verified the tax mechanics of a rollover and won't guess at them.

If a structure you're considering includes retained equity, it goes to your tax adviser before you sign, not after.

Serial acquisition is also what draws regulators in.

The FTC's June 2022 order on JAB's $1.1 billion acquisition of SAGE Veterinary Partners didn't stop at requiring divestitures of clinics in California and Texas — it required JAB to get the FTC's prior approval before acquiring any specialty or emergency veterinary clinic within 25 miles of a clinic it already owned in those states.

A prior-approval condition is a remedy built for a buyer expected to keep buying.

The honest answer first: there is no current, sourced national figure for the share of U.S. veterinary practices owned by corporate groups or private equity.

Published estimates differ depending on where they draw the line between a corporate chain, a PE-backed platform and any multi-site group, so treat any precise percentage you come across with care — including in this article, where we've left that number out on purpose.

One related statistic is easy to misread.

Census-based AVMA data show individual proprietorships fell from 19.7% of U.S. veterinary practices in 2012 to 9.9% in 2022.

That is a change in legal form, not in who owns a practice or how many owners it has, so it is not a measure of consolidation or corporate ownership.

The last fully publishable scale counts are older, and we date-stamp them for that reason.

In 2018, JAVMA News reported AVMA's estimate of 28,000 to 32,000 U.S. veterinary practices, a Brakke Consulting estimate putting company-owned practices at 3,500, and a further Brakke estimate that corporations owned 10 percent of general companion animal practices and 40 to 50 percent of referral practices.

Those are 2018 figures, not current ones — but they explain why consolidation reads differently in general practice than in referral work.

One caution about survey numbers.

AVMA's 2024 owner survey sample was 93.9% independently owned practices — a description of who answered that survey, not a measure of the national market.

If you see that figure quoted as proof the profession is still overwhelmingly independent, you're reading a sample description as a market share.

Measurement is also hard because consolidation is uneven.

The trend the FTC's Ethos complaint described was concentrated in emergency and specialty services, and a single platform can be very large on its own — Thrive's self-described count alone was over 360 hospitals in March 2025.

The closing is the start of the changes, not the end of them.

What happens next varies by acquirer, and we found no primary-source playbook for how staff benefits change after a corporate acquisition — any list of "typical" changes would be guessing.

What you can do is pin down the areas where the new owner's decisions will reach your working life:

• Systems and operations. Whose practice-management software, purchasing, accounting and marketing will the clinic run on, and on what timeline? This is where most of the day-to-day difference shows up, so ask for the plan in writing.
• Accreditation. Group-level programs exist: AAHA offers an "Amplify" group accreditation for hospitals within corporate veterinary enterprise groups. Ask whether the clinic keeps its own accreditation status and who maintains it.
• Pay and benefits. How do current salaries, production or bonus arrangements, CE allowance, PTO, health coverage and retirement plans map onto the group's plans on day one, and what reviews come after?
• Autonomy. What stays decided at the clinic — hours, staffing, inventory, protocols, hiring — and what moves to group leadership? Get the answer in the agreement, not in a verbal assurance.
• Contracts. Ask whether the deal brings new employment agreements; the clause most people fixate on is the non-compete.

On non-competes, the federal story is now settled: the FTC's 2024 Non-Compete Clause Rule was set aside in court and never took effect — it is not in effect and not enforceable — and in a final rule effective February 12, 2026 the FTC removed the Non-Compete Rule from the Code of Federal Regulations.

What governs any non-compete attached to your sale or your employment is state law, and state law is where these clauses genuinely differ.

Our veterinarian non-compete rules by state series covers what each state does with them.

A covenant signed as part of selling a practice is exactly the thing to take to an attorney licensed in your state before you sign.

If you own the practice, consolidation is optionality and complexity at once.

Platform buyers sit at the table alongside individual buyers and associates seeking a first practice, and a deal can bundle cash, retained equity and your continued employment.

Each thread has its own diligence — the equity and tax threads above all, since that's the part this page deliberately won't do for you.

If you stay on through a transition, the acquisition questions in the list above are the ones to negotiate in writing.

If you're an associate veterinarian, consolidation usually reaches you through your contract and your pay plan: who employs you, how salary and production are structured, what the schedule looks like, and what your non-compete says under your state's law.

When the question is which kind of practice to build a career in — a corporate-backed group or an independent — that's the job-seeker's decision, and it has its own guide: corporate vs private practice careers covers the trade-offs from that side, so we won't re-argue them here.

If you're a technician, assistant, receptionist or kennel staff, the practical version is the same list with different paperwork: how your pay bands translate, who schedules you, who you report to, and whether the group's benefits are better or merely different from what you had.

In at least one deal, regulators treated experienced-staff retention as material — the FTC's Mars/VCA order required the buyer to provide reasonable financial incentives for key employees at the divested clinics to continue in their positions.

Keeping a trained team is part of what gets bought.

For hiring, consolidation changes who sits on the other side of the table.

Large groups run recruiting for many locations at once and can source candidates across a wider geography than a single practice does.

An independent practice in a market with an active platform is recruiting against that platform's pay, benefits and scheduling — not just the practice down the street.

None of that tells you whose offer is better; it means the comparison set has changed.

The squeeze is sharpest where the candidates are scarcest, and the FTC said so itself: opening a specialty or emergency clinic, the agency noted in the Mars/VCA action, presents "some unique challenges, including the need to recruit specialist veterinarians with considerably greater training than general practice veterinarians."

When large chains expand in emergency and specialty care — the trend the Ethos complaint described — they compete for exactly that pool.

The Mars/VCA order went as far as prohibiting Mars, for a year after the order took effect, from entering into contracts with any specialty or emergency veterinarian affiliated with a divested clinic.

Coverage arrangements matter here too.

After public comment, the FTC altered its final Mars/VCA order in December 2017 specifically to let long-standing arrangements that permit veterinarians at different clinics to cover for each other temporarily continue — the order was adjusted so it didn't break those arrangements.

If you're hiring into this market, compete on the things a platform playbook doesn't decide for you: a pay structure that holds up in your market, a schedule people can live on, and a concrete case for why your practice is a good place to do the work.

Our associate veterinarian salary guide and vet tech salary guide cover how each role is paid, and the how to hire a veterinarian hub walks the process end to end.